Facebook Pixel Coliform bacteria and E. coli in pharma water systems: A hidden threat to product integrity | Express Pharma - health - Lisez cet article sur Magzter.com
Passez à l'illimité avec Magzter GOLD

Passez à l'illimité avec Magzter GOLD

Obtenez un accès illimité à plus de 9 000 magazines, journaux et articles Premium pour seulement

$149.99
 
$74.99/Année

Essayer OR - Gratuit

Coliform bacteria and E. coli in pharma water systems: A hidden threat to product integrity

Express Pharma

|

May 2025

Water quality is critical in pharma manufacturing, and contamination by coliforms or E. coli can threaten product safety and compliance. Dr Girish B Mahajan, Sr VP - Microbiology, HiMedia Laboratories examines the risks, regulatory focus, and new technologies for real-time microbial monitoring in this article

Coliform bacteria and E. coli in pharma water systems: A hidden threat to product integrity

The COVID-19 pandemic brought microbiology to the public eye, making terms like RT-PCR, antigen, and PPE kit part of everyday discussions. In the pharmaceutical world, another set of terms-coliforms and E. coli-carry immense importance, especially where water quality is concerned. Water is a critical utility in pharma manufacturing processes and is used in various stages including formulation, cleaning, and even as raw material in some products. Any microbial contamination in the water supply chain can have cascading effects on product integrity, batch sterility, and ultimately patient safety.

Pharma-grade water systems like Purified Water (PW), Water for Injection (WFI), and Clean-in-Place (CIP) are designed with rigorous microbial quality parameters. However, coliform bacteria-especially E. coli-serve as early indicators of water system failures and contamination by fecal matter or biofilm development. A recent E. coli outbreak in 2024 due to contaminated food illustrated how lapses in microbial control can spiral into public health emergencies. For the pharma industry, the implications are even more severe, with potential regulatory actions, product recalls, and brand damage.

Understanding coliforms and their relevance in pharma

Coliform bacteria, comprising genera such as Escherichia, Citrobacter, Enterobacter, and Klebsiella, are Gram-negative, rod-shaped microorganisms commonly found in the environment, including soil, surface water, and the gastrointestinal tracts of warm-blooded animals. Though most are not pathogenic, their presence in pharma water systems-especially Escherichia coli, which indicates faecal origin-raises serious red flags regarding the integrity of production processes.

PLUS D'HISTOIRES DE Express Pharma

Express Pharma

Express Pharma

Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?

Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing

time to read

5 mins

May 2026

Express Pharma

Express Pharma

Ensuring Pharma compliance with testo data measurement technology

Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.

time to read

3 mins

May 2026

Express Pharma

Express Pharma

China+1 moment for pharma: How India can convert opportunity into long-term contracts

Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner

time to read

3 mins

May 2026

Express Pharma

Express Pharma

Beyond scale: Rethinking new frontiers in building excellence

At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports

time to read

10 mins

May 2026

Express Pharma

Express Pharma

Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR

Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement

time to read

2 mins

May 2026

Express Pharma

Express Pharma

JNPC: Carrying forward a 20-year old legacy

Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.

time to read

3 mins

May 2026

Express Pharma

Express Pharma

Romaco's sustainable blister packaging line at interpack

At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.

time to read

6 mins

May 2026

Express Pharma

Express Pharma

Even drug-resistant cancer targets can be tackled with the right design strategy

Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma

time to read

7 mins

May 2026

Express Pharma

Express Pharma

Navigating legal and regulatory landscape of GLP-1 drugs in India

GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders

time to read

5 mins

May 2026

Express Pharma

Express Pharma

From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India

Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact

time to read

4 mins

May 2026

Listen

Translate

Share

-
+

Change font size